Artificial intelligence aids in development of nanomedicines for cancer management
P Tan, X Chen, H Zhang, Q Wei, K Luo - Seminars in cancer biology, 2023 - Elsevier
Over the last decade, the nanomedicine has experienced unprecedented development in
diagnosis and management of diseases. A number of nanomedicines have been approved …
diagnosis and management of diseases. A number of nanomedicines have been approved …
[HTML][HTML] Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges
C Duan, M Yu, J Xu, BY Li, Y Zhao… - Biomedicine & …, 2023 - Elsevier
Multi-drug resistance (MDR) in cancer cells, either intrinsic or acquired through various
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …
Stimuli-responsive electrospun nanofibers for drug delivery, cancer therapy, wound dressing, and tissue engineering
K Chen, Y Li, Y Li, Y Tan, Y Liu, W Pan… - Journal of …, 2023 - Springer
The stimuli-responsive nanofibers prepared by electrospinning have become an ideal
stimuli-responsive material due to their large specific surface area and porosity, which can …
stimuli-responsive material due to their large specific surface area and porosity, which can …
Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation
Cancer radio-immunotherapy, integrating external/internal radiation therapy with immuno-
oncology treatments, emerges in the current management of cancer. A growing number of …
oncology treatments, emerges in the current management of cancer. A growing number of …
[HTML][HTML] Ru (II)-modified TiO2 nanoparticles for hypoxia-adaptive photo-immunotherapy of oral squamous cell carcinoma
JY Zhou, WJ Wang, CY Zhang, YY Ling, XJ Hong, Q Su… - Biomaterials, 2022 - Elsevier
The alternations in the hypoxic and immune microenvironment are closely related to the
therapeutic effect and prognosis of oral squamous cell carcinoma (OSCC). Herein, a new …
therapeutic effect and prognosis of oral squamous cell carcinoma (OSCC). Herein, a new …
The current status of photodynamic therapy in cancer treatment
W Jiang, M Liang, Q Lei, G Li, S Wu - Cancers, 2023 - mdpi.com
Simple Summary Photodynamic therapy (PDT), a non-invasive cancer treatment strategy,
has presented a broad scope in future clinical applications. This review mainly summarizes …
has presented a broad scope in future clinical applications. This review mainly summarizes …
[HTML][HTML] Advances and challenges in the treatment of lung cancer
Y Li, B Yan, S He - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Lung cancer accounts for a relatively high proportion of malignant tumors. As the most
prevalent type of lung cancer, non-small cell lung cancer (NSCLC) is characterized by high …
prevalent type of lung cancer, non-small cell lung cancer (NSCLC) is characterized by high …
Engineered Bio‐Heterojunction with Infection‐Primed H2S Liberation for Boosted Angiogenesis and Infectious Cutaneous Regeneration
Y Huang, Y Huang, Z Wang, S Yu, HM Johnson… - Small, 2023 - Wiley Online Library
Photodynamic therapy (PDT) acts as a powerful weapon against infectious diseases for its
enormous antimicrobial activity that quickly elicits storms of reactive oxygen species (ROS) …
enormous antimicrobial activity that quickly elicits storms of reactive oxygen species (ROS) …
Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery
H Wang, L Qin, X Zhang, J Guan, S Mao - Journal of Controlled Release, 2022 - Elsevier
With the rapid development of biopharmaceuticals and the outbreak of COVID-19, the world
has ushered in a frenzy to develop gene therapy. Therefore, therapeutic genes have …
has ushered in a frenzy to develop gene therapy. Therefore, therapeutic genes have …
Nanomedicine combats drug resistance in lung cancer
Lung cancer is the second most prevalent cancer and the leading cause of cancer‐related
death worldwide. Surgery, chemotherapy, molecular targeted therapy, immunotherapy, and …
death worldwide. Surgery, chemotherapy, molecular targeted therapy, immunotherapy, and …